Bazinet, A., Bataller, A., Montalban-Bravo, G., Chien, K., Sasaki, K., Jen, W. Y., . . . Kantarjian, H. (2025). PTPN11 mutations define a rare but highly adverse subset of myelodysplastic syndromes. Ferrata Storti Foundation.
Chicago Style (17th ed.) CitationBazinet, Alexandre, et al. PTPN11 Mutations Define a Rare but Highly Adverse Subset of Myelodysplastic Syndromes. Ferrata Storti Foundation, 2025.
MLA (9th ed.) CitationBazinet, Alexandre, et al. PTPN11 Mutations Define a Rare but Highly Adverse Subset of Myelodysplastic Syndromes. Ferrata Storti Foundation, 2025.
Warning: These citations may not always be 100% accurate.